Assessment of premature mortality for noncommunicable diseases
نویسندگان
چکیده
منابع مشابه
Noncommunicable diseases.
From the Departments of Epidemiology and Nutrition, Harvard School of Public Health, Boston (D.J.H.); the Public Health Foundation of India, New Delhi (K.S.R.); and the World Heart Federation, Geneva (K.S.R.). Address reprint requests to Dr. Hunter at the Departments of Epidemiology and Nutrition, Harvard School of Public Health, 677 Huntington Ave., Boston, MA 02115, or at [email protected]...
متن کاملdiagnostic and developmental potentials of dynamic assessment for writing skill
این پایان نامه بدنبال بررسی کاربرد ارزیابی مستمر در یک محیط یادگیری زبان دوم از طریق طرح چهار سوال تحقیق زیر بود: (1) درک توانایی های فراگیران زمانیکه که از طریق برآورد عملکرد مستقل آنها امکان پذیر نباشد اما در طول جلسات ارزیابی مستمر مشخص شوند; (2) امکان تقویت توانایی های فراگیران از طریق ارزیابی مستمر; (3) سودمندی ارزیابی مستمر در هدایت آموزش فردی به سمتی که به منطقه ی تقریبی رشد افراد حساس ا...
15 صفحه اولTrends and inequalities in mortality of noncommunicable diseases: Case study for Estonia
This case study aims to provide a comprehensive overview of trends and inequalities in mortality of noncommunicable diseases in Estonia over the first decade of the 2000s. Decomposition of life expectancy by causes and age groups, and calculation of age-standardized rates for total and cause-specific mortality were used to assess differences over time and across social groups. The findings of t...
متن کامل10 . Noncommunicable diseases and prisoners
Key points • The global burden of and threat from noncommunicable diseases (NCDs) constitute a major public health challenge that undermines social and economic development throughout the world. Prisoners are at greater risk for such diseases. • Most information on NCDs in prisoners comes from high-income countries despite the fact that globally, 80% of these deaths from these diseases are in l...
متن کاملPragmatic Trials for Noncommunicable Diseases: Relieving Constraints
In this month's editorial, PLOS Medicine Editorial Board member Anushka Patel and Ruth Webster discuss how applying rules for drug efficacy trials can impede pragmatic trials of interventions for noncommunicable diseases.
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Revista Brasileira de Enfermagem
سال: 2020
ISSN: 1984-0446,0034-7167
DOI: 10.1590/0034-7167-2018-0440